$43.91
0.140.32%
al cierre: -
$43.36
-0.55-1.25%
After hour: 9:29 AM EDT
GSK emite una orientación sobre las ganancias por acción y los ingresos futuros, lo que ofrece a los inversores una idea de cuánto espera ganar la empresa en los próximos períodos.
Get Alert | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
07/30/2025 | GSK | GSK | FY | 2025 | $4.59 | $4.59 | $4.34 | $42.71B | $42.71B | $42.16B | |
04/30/2025 | GSK | GSK | FY | 2025 | $4.25 | $4.59 | $4.36 | $40.68B | $42.71B | $32.61B | |
02/05/2025 | GSK | GSK | FY | 2025 | $4.18 | $4.26 | $4.52 | $40.07B | $40.85B | $34.29B | |
10/30/2024 | GSK | GSK | FY | 2024 | $1.71 | $1.74 | $4.06 | $40.94B | $41.71B | $41.46B | |
07/31/2024 | GSK | GSK | FY | 2024 | $1.71 | $1.74 | $4.04 | $40.94B | $41.71B | $40.67B | |
05/01/2024 | GSK | GSK | FY | 2024 | $2.12 | $2.16 | $3.96 | $41.16B | $41.16B | $39.57B | |
01/31/2024 | GSK | GSK | FY | 2024 | $1.64 | $1.69 | $4.05 | $39.53B | $40.29B | $39.82B | |
11/01/2023 | GSK | GSK | FY | 2023 | $2.07 | $2.12 | $3.86 | $41.58B | $41.95B | $35.50B | |
07/26/2023 | GSK | GSK | FY | 2023 | $1.99 | $2.05 | $3.80 | $39.63B | $40.37B | $37.43B | |
04/26/2023 | GSK | GSK | FY | 2023 | $1.90 | $1.96 | $3.68 | $37.75B | $38.47B | $35.72B | |
02/01/2023 | GSK | GSK | FY | 2023 | $1.94 | $1.99 | $3.64 | $38.54B | $39.27B | $35.92B | |
11/02/2022 | GSK | GSK | FY | 2022 | — | — | — | $50.67B | $51.60B | $32.29B | |
07/27/2022 | GSK | GSK | FY | 2022 | — | — | — | $49.73B | $50.67B | $38.72B | |
10/27/2021 | GSK | GlaxoSmithKline | FY | 2021 | $1.56 | $1.59 | $2.86 | — | — | — |
La orientación más reciente para GSK (GSK) se informó el julio 30, 2025 para el año completo 2025. La empresa proporcionó una guía de ganancias por acción en el rango de $4.59 a $4.59, en comparación con el EPS estimado de $4.34. Además, GSK pronosticó ingresos entre $42.71B y $42.71B para el trimestre.
Explora orientación y previsión sobre todos los valores.